Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of Nov. 21)
Release Date:
In this week’s View, Dr. Eagle discusses trends in the use of oral anticoagulants in older adults with newly diagnosed atrial fibrillation, then looks at a collaborative meta-analysis of large placebo-controlled trials that examines the impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes. Finally, Dr. Eagle explores insights from the PEGASUS-TIMI 54 trial regarding patient selection for long-term secondary prevention with ticagrelor. Subscribe to Eagle’s Eye View
Eagle’s Eye View: Your Weekly CV Update from ACC.org (Week of Nov. 21)